Blueprint Medicines Corp - COM (BPMC)

Historical Portfolio Holders from Q2 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
63.7 M
Holdings value Q1 2024
$6.04 B
Value change Q1 2024
+$131 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
266
Number of buys Q1 2024
147
Number of sells Q1 2024
-111
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.002%
CUSIP
09627Y109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 63.7 M $6.04 B +$131 M $94.86 273
2023 Q4 62.4 M $5.76 B -$117 M $92.24 253
2023 Q3 63.7 M $3.2 B +$13.4 M $50.22 212
2023 Q2 62.7 M $3.96 B +$29 M $63.20 212
2023 Q1 63.2 M $2.84 B +$37.4 M $44.99 210
2022 Q4 62.5 M $2.74 B -$85.3 M $43.81 214
2022 Q3 60.9 M $4.01 B -$119 M $65.89 214
2022 Q2 53.8 M $2.72 B -$14.2 M $50.51 213
2022 Q1 59.2 M $3.78 B -$42.9 M $63.88 222
2021 Q4 58.5 M $6.27 B -$36 M $107.11 261
2021 Q3 59.5 M $6.12 B +$226 M $102.81 278
2021 Q2 53.8 M $4.73 B -$33.9 M $87.96 271
2021 Q1 53.9 M $5.24 B +$94.3 M $97.23 253
2020 Q4 53.1 M $5.96 B +$30.6 M $112.15 263
2020 Q3 52.8 M $4.89 B +$120 M $92.70 227
2020 Q2 52.4 M $4.08 B +$187 M $78.00 220
2020 Q1 54.4 M $3.18 B +$194 M $58.48 196
2019 Q4 50.6 M $4.05 B -$62.5 M $80.11 216
2019 Q3 51.3 M $3.77 B +$142 M $73.47 208
2019 Q2 49.5 M $4.67 B +$407 M $94.33 213
2019 Q1 48.4 M $3.88 B +$227 M $80.05 193
2018 Q4 45.5 M $2.45 B -$76.8 M $53.91 152
2018 Q3 44.8 M $3.49 B +$28.7 M $78.06 184
2018 Q2 44.3 M $2.81 B +$189 M $63.48 174
2018 Q1 41.2 M $3.78 B +$86.8 M $91.70 174
2017 Q4 42.7 M $3.22 B +$300 M $75.41 165
2017 Q3 36.3 M $2.53 B +$48.1 M $69.67 136
2017 Q2 35.6 M $1.8 B +$85.5 M $50.67 123
2017 Q1 34.7 M $1.38 B +$410 M $39.99 134
2016 Q4 26 M $729 M +$172 M $28.05 101
2016 Q3 19.1 M $568 M +$17.1 M $29.70 86
2016 Q2 19.5 M $395 M +$32.9 M $20.25 81
2016 Q1 17.9 M $323 M -$4.07 M $18.05 71
2015 Q4 18 M $474 M +$22.3 M $26.34 74
2015 Q3 23 M $489 M +$12.8 M $21.34 67
2015 Q2 23.1 M $609 M +$586 M $26.49 67